These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 28316135)

  • 61. Interactions between rivaroxaban and antiphospholipid antibodies in thrombotic antiphospholipid syndrome.
    Arachchillage DR; Mackie IJ; Efthymiou M; Isenberg DA; Machin SJ; Cohen H
    J Thromb Haemost; 2015 Jul; 13(7):1264-73. PubMed ID: 25850997
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Mixing studies in lupus anticoagulant testing are required at least in some type of samples.
    Devreese KM; de Laat B
    J Thromb Haemost; 2015 Aug; 13(8):1475-8. PubMed ID: 26017873
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Sensitivity of sixteen APTT reagents for the presence of lupus anticoagulants.
    Denis-Magdelaine A; Flahault A; Verdy E
    Haemostasis; 1995; 25(3):98-105. PubMed ID: 7607585
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Lupus anticoagulant testing in Europe: an analysis of results from the first European Concerted Action on Thrombophilia (ECAT) survey using plasmas spiked with monoclonal antibodies against human beta2-glycoprotein I.
    Arnout J; Meijer P; Vermylen J
    Thromb Haemost; 1999 Jun; 81(6):929-34. PubMed ID: 10404770
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Lupus anticoagulant testing using two parallel methods detects additional cases and predicts persistent positivity.
    Simmons DP; Herskovits AZ; Battinelli EM; Schur PH; Lemire SJ; Dorfman DM
    Clin Chem Lab Med; 2018 Jul; 56(8):1289-1296. PubMed ID: 27305702
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Practical Considerations and Testing Nuances for the Detection of Lupus Anticoagulant: Do Low Phospholipid Screen Results, Assay Type, and Test Ratio Matter?
    Asakrah S; Davis R; Bhargava P
    Am J Clin Pathol; 2021 Nov; 156(6):1073-1082. PubMed ID: 34075395
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Interference of lupus anticoagulants in prothrombin time assays: implications for selection of adequate methods to optimize the management of thrombosis in the antiphospholipid-antibody syndrome.
    Della Valle P; Crippa L; Garlando AM; Pattarini E; Safa O; Viganò D'Angelo S; D'Angelo A
    Haematologica; 1999 Dec; 84(12):1065-74. PubMed ID: 10586206
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Cross-mixing test to detect lupus anticoagulant for diagnosis of antiphospholipid syndrome].
    Ieko M; Naito S; Yoshida M
    Rinsho Byori; 2009 Oct; 57(10):990-8. PubMed ID: 19928497
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Optimisation of lupus anticoagulant tests: should test samples always be mixed with normal plasma?
    Pennings MT; De Groot PG; Meijers JC; Huisman A; Derksen RH; Urbanus RT
    Thromb Haemost; 2014 Oct; 112(4):736-42. PubMed ID: 25008787
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Update of the guidelines for lupus anticoagulant detection. Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the International Society on Thrombosis and Haemostasis.
    Pengo V; Tripodi A; Reber G; Rand JH; Ortel TL; Galli M; De Groot PG;
    J Thromb Haemost; 2009 Oct; 7(10):1737-40. PubMed ID: 19624461
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The Lupus Ratio test--an interlaboratory study on the detection of Lupus anticoagulants by an APTT-based, integrated, and semi-quantitative test. Fifth International Survey of Lupus Anticoagulants--ISLA 5.
    Jacobsen EM; Barna-Cler L; Taylor JM; Triplett DA; Wisløff F
    Thromb Haemost; 2000 May; 83(5):704-8. PubMed ID: 10823266
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Sensitivity of the activated partial thromboplastin time, the dilute Russell's viper venom time, and the kaolin clotting time for the detection of the lupus anticoagulant: a direct comparison using plasma dilutions.
    Martin BA; Branch DW; Rodgers GM
    Blood Coagul Fibrinolysis; 1996 Jan; 7(1):31-8. PubMed ID: 8845460
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Effects of direct oral anticoagulants on lupus anticoagulant assays in a real-life setting.
    Antovic A; Norberg EM; Berndtsson M; Rasmuson A; Malmström RE; Skeppholm M; Antovic J
    Thromb Haemost; 2017 Aug; 117(9):1700-1704. PubMed ID: 28640321
    [TBL] [Abstract][Full Text] [Related]  

  • 74. An Acute Need Inspiration: Autoneutralization of Lupus Anticoagulants in Affected Prothrombin Times (PT) and Activated Partial Thromboplastin Times (APTT).
    Gosselin RC
    Methods Mol Biol; 2023; 2663():289-295. PubMed ID: 37204718
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Laboratory diagnostic outcome applying detection criteria recommended by the Scientific and Standardization Committee of the ISTH on Lupus Anticoagulant.
    Chantarangkul V; Biguzzi E; Asti D; Palmucci C; Tripodi A
    Thromb Haemost; 2013 Jul; 110(1):46-52. PubMed ID: 23615569
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Lupus anticoagulants and thrombosis: clinical association of different coagulation and immunologic tests.
    Galli M; Dlott J; Norbis F; Ruggeri L; Cler L; Triplett DA; Barbui T
    Thromb Haemost; 2000 Dec; 84(6):1012-6. PubMed ID: 11154107
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Evaluation of four coagulation tests to detect plasma lupus anticoagulants.
    Saxena R; Saraya AK; Kotte VK; Singh YN; Prasad L; Malviya AN
    Am J Clin Pathol; 1991 Dec; 96(6):755-8. PubMed ID: 1746492
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Reference intervals of the dilute tissue thromboplastin inhibition and dilute Russell's viper venom tests revisited.
    Gerbutavicius R; Fareed J; Messmore HL; Iqbal O; Hoppensteadt DA; Wehrmacher WH; Demir M; Piccolo P; Ahmad S; Ma Q; Griniute R
    Clin Appl Thromb Hemost; 2002 Apr; 8(2):115-24. PubMed ID: 12121051
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Reliability of Lupus Anticoagulant and Anti-phosphatidylserine/prothrombin Autoantibodies in Antiphospholipid Syndrome: A Multicenter Study.
    Sciascia S; Radin M; Cecchi I; Rubini E; Scotta A; Rolla R; Montaruli B; Pergolini P; Mengozzi G; Muccini E; Baldovino S; Ferro M; Vaccarino A; Mahler M; Menegatti E; Roccatello D
    Front Immunol; 2019; 10():376. PubMed ID: 30891041
    [No Abstract]   [Full Text] [Related]  

  • 80. As compared to kaolin clotting time, silica clotting time is a specific and sensitive automated method for detecting lupus anticoagulant.
    Dragoni F; Minotti C; Palumbo G; Faillace F; Redi R; Bongarzoni V; Avvisati G
    Thromb Res; 2001 Jan; 101(2):45-51. PubMed ID: 11342205
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.